Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Application
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map
6. Global Herpes Simplex Virus (HSV) Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Virus Type (HSV-1 v/s HSV-2)
6.2.2. By Treatment (Drugs v/s Vaccines)
6.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
6.2.2.2. By Vaccines (Simplirix, Others)
6.2.3. By Route of Administration (Oral, Intravenous, Topical)
6.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
6.2.5. By Region
6.2.6. By Company (2022)
6.3. Market Map
6.3.1. By Virus Type
6.3.2. By Treatment
6.3.3. By Route of Administration
6.3.4. By Distribution Channel
7. North America Herpes Simplex Virus (HSV) Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Virus Type (HSV-1 v/s HSV-2)
7.2.2. By Treatment (Drugs v/s Vaccines)
7.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
7.2.2.2. By Vaccines (Simplirix, Others)
7.2.3. By Route of Administration (Oral, Intravenous, Topical)
7.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Herpes Simplex Virus (HSV) Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Virus Type
7.3.1.2.2. By Treatment
7.3.1.2.3. By Route of Administration
7.3.1.2.4. By Distribution Channel
7.3.2. Canada Herpes Simplex Virus (HSV) Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Virus Type
7.3.2.2.2. By Treatment
7.3.2.2.3. By Route of Administration
7.3.2.2.4. By Distribution Channel
7.3.3. Mexico Herpes Simplex Virus (HSV) Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Virus Type
7.3.3.2.2. By Treatment
7.3.3.2.3. By Route of Administration
7.3.3.2.4. By Distribution Channel
8. Europe Herpes Simplex Virus (HSV) Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Virus Type (HSV-1 v/s HSV-2)
8.2.2. By Treatment (Drugs v/s Vaccines)
8.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
8.2.2.2. By Vaccines (Simplirix, Others)
8.2.3. By Route of Administration (Oral, Intravenous, Topical)
8.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Herpes Simplex Virus (HSV) Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Virus Type
8.3.1.2.2. By Treatment
8.3.1.2.3. By Route of Administration
8.3.1.2.4. By Distribution Channel
8.3.2. Germany Herpes Simplex Virus (HSV) Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Virus Type
8.3.2.2.2. By Treatment
8.3.2.2.3. By Route of Administration
8.3.2.2.4. By Distribution Channel
8.3.3. United Kingdom Herpes Simplex Virus (HSV) Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Virus Type
8.3.3.2.2. By Treatment
8.3.3.2.3. By Route of Administration
8.3.3.2.4. By Distribution Channel
8.3.4. Italy Herpes Simplex Virus (HSV) Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Virus Type
8.3.4.2.2. By Treatment
8.3.4.2.3. By Route of Administration
8.3.4.2.4. By Distribution Channel
8.3.5. Spain Herpes Simplex Virus (HSV) Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Virus Type
8.3.5.2.2. By Treatment
8.3.5.2.3. By Route of Administration
8.3.5.2.4. By Distribution Channel
9. Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Virus Type (HSV-1 v/s HSV-2)
9.2.2. By Treatment (Drugs v/s Vaccines)
9.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
9.2.2.2. By Vaccines (Simplirix, Others)
9.2.3. By Route of Administration (Oral, Intravenous, Topical)
9.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Herpes Simplex Virus (HSV) Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Virus Type
9.3.1.2.2. By Treatment
9.3.1.2.3. By Route of Administration
9.3.1.2.4. By Distribution Channel
9.3.2. India Herpes Simplex Virus (HSV) Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Virus Type
9.3.2.2.2. By Treatment
9.3.2.2.3. By Route of Administration
9.3.2.2.4. By Distribution Channel
9.3.3. Japan Herpes Simplex Virus (HSV) Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Virus Type
9.3.3.2.2. By Treatment
9.3.3.2.3. By Route of Administration
9.3.3.2.4. By Distribution Channel
9.3.4. South Korea Herpes Simplex Virus (HSV) Treatment Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Virus Type
9.3.4.2.2. By Treatment
9.3.4.2.3. By Route of Administration
9.3.4.2.4. By Distribution Channel
9.3.5. Australia Herpes Simplex Virus (HSV) Treatment Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Virus Type
9.3.5.2.2. By Treatment
9.3.5.2.3. By Route of Administration
9.3.5.2.4. By Distribution Channel
10. South America Herpes Simplex Virus (HSV) Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Virus Type (HSV-1 v/s HSV-2)
10.2.2. By Treatment (Drugs v/s Vaccines)
10.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
10.2.2.2. By Vaccines (Simplirix, Others)
10.2.3. By Route of Administration (Oral, Intravenous, Topical)
10.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Herpes Simplex Virus (HSV) Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Virus Type
10.3.1.2.2. By Treatment
10.3.1.2.3. By Route of Administration
10.3.1.2.4. By Distribution Channel
10.3.2. Argentina Herpes Simplex Virus (HSV) Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Virus Type
10.3.2.2.2. By Treatment
10.3.2.2.3. By Route of Administration
10.3.2.2.4. By Distribution Channel
10.3.3. Colombia Herpes Simplex Virus (HSV) Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Virus Type
10.3.3.2.2. By Treatment
10.3.3.2.3. By Route of Administration
10.3.3.2.4. By Distribution Channel
11. Middle East and Africa Herpes Simplex Virus (HSV) Treatment Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Virus Type (HSV-1 v/s HSV-2)
11.2.2. By Treatment (Drugs v/s Vaccines)
11.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
11.2.2.2. By Vaccines (Simplirix, Others)
11.2.3. By Route of Administration (Oral, Intravenous, Topical)
11.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Herpes Simplex Virus (HSV) Treatment Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Virus Type
11.3.1.2.2. By Treatment
11.3.1.2.3. By Route of Administration
11.3.1.2.4. By Distribution Channel
11.3.2. Saudi Arabia Herpes Simplex Virus (HSV) Treatment Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Virus Type
11.3.2.2.2. By Treatment
11.3.2.2.3. By Route of Administration
11.3.2.2.4. By Distribution Channel
11.3.3. UAE Herpes Simplex Virus (HSV) Treatment Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Virus Type
11.3.3.2.2. By Treatment
11.3.3.2.3. By Route of Administration
11.3.3.2.4. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Recent Developments
13.2. Mergers & Acquisitions
13.3. Product Launches
14. Competitive Landscape
14.1. Business Overview
14.2. Company Snapshot
14.3. Products & Services
14.4. Financials (As reported)
14.5. Recent Developments
14.6. SWOT Analysis
14.6.1. Novartis International AG
14.6.2. GlaxoSmithKline, plc.
14.6.3. Sanofi SA
14.6.4. Mylan N.V.
14.6.5. Emcure Pharmaceuticals Ltd.
14.6.6. Glenmark Pharmaceuticals Inc.
14.6.7. Fresenius Kabi AG
14.6.8. Apotex Inc.
14.6.9. Viatris Inc.
14.6.10. Teva Pharmaceuticals Industries Ltd
15. Strategic Recommendations